Copyright
©The Author(s) 2024.
World J Transplant. Mar 18, 2024; 14(1): 90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Published online Mar 18, 2024. doi: 10.5500/wjt.v14.i1.90277
Table 1 Etiology and classification of thrombotic microangiopathies
| Primary TMAs | |
| Shiga toxin-producing E. Coli-associated HUS | |
| Thrombotic thrombocytopenic purpura | |
| Atypical HUS or complement-mediated | |
| Secondary TMAs | |
| Infections including viral, fungal, and bacterial | |
| Drugs including immunosuppressants and chemotherapeutic agents | |
| Autoimmune diseases | |
| Malignant hypertension | |
| Malignancy | |
| Metabolic defects | |
| Pregnancy | |
| Transplantation, both hematopoietic stem cell transplantation and solid organ transplantation | |
| Disseminated intravascular coagulation | |
| Radiation | |
Table 2 Etiology of post-transplant thrombotic microangiopathies
| Recurrent TMA, rare (5%-10% of cases) |
| Mutations in complement regulatory factor genes [e.g., factor H, factor I, membrane cofactor protein, etc.] |
| Mutations in complement genes (e.g., C3) |
| TMA associated with autoantibodies (anti-factor H antibodies, anti-ADAMTS13 antibodies, antiphospholipid antibodies) |
| TMA associated with autoimmune diseases (scleroderma and systemic lupus erythematosus) |
| De-novo TMA, common (90%-95% of cases) |
| Associated with the type of donor and organ procurement procedure, e.g. Ischemia reperfusion injury |
| Drugs |
| I: Calcineurin inhibitors-associated TMA |
| II: Mammalian target of rapamycin inhibitors-associated TMA |
| Antibody-mediated rejection associated TMA |
| Infection-associated TMA |
| I: Viral, e.g. hepatitis C virus, parvovirus B19, and cytomegalovirus) |
| II: Fungal |
| III: Bacterial |
| Other rare causes, such as malignancy, other drugs, and pregnancy |
Table 3 Morphological features of thrombotic microangiopathies
| Active lesions | ||
| 1 Glomerular lesions (Light microscopy): | ||
| Intraluminal thrombi | ||
| Endothelial swelling or denudation | ||
| Endothelial swelling or denudation | ||
| Subendothelial space widening (bloodless glomeruli) | ||
| Mesangiolysis | ||
| Microaneurysms | ||
| 2 Arteriolar lesions: | ||
| Intraluminal thrombi | ||
| Endothelial swelling or denudation | ||
| Intramural fibrin | ||
| Fragmented red blood cells | ||
| 3 Arterial lesions: | ||
| Intraluminal thrombi | ||
| Intimal edema | ||
| Myxoid intimal swelling | ||
| Myocyte necrosis | ||
| Intramural fibrin | ||
| Fragmentation of red blood cells | ||
| Chronic lesions | ||
| 1 Glomerular lesions (Light microscopy): | ||
| Double contours of peripheral capillary walls, with variable mesangial interposition | ||
| 2 Arteriolar lesions: | ||
| Hyaline deposits | ||
| 3 Arterial lesions: | ||
| Fibrous intimal thickening with concentric lamination (onion-skining) | ||
- Citation: Mubarak M, Raza A, Rashid R, Sapna F, Shakeel S. Thrombotic microangiopathy after kidney transplantation: Expanding etiologic and pathogenetic spectra. World J Transplant 2024; 14(1): 90277
- URL: https://www.wjgnet.com/2220-3230/full/v14/i1/90277.htm
- DOI: https://dx.doi.org/10.5500/wjt.v14.i1.90277
